Cargando…
Safety evaluation of high‐dose intake of casein‐derived peptide Met‐Lys‐Pro in healthy adults: A randomized, double‐blind, placebo‐controlled trial
Met‐Lys‐Pro (MKP) is a casein‐derived angiotensin I‐converting enzyme inhibitory peptide with the potential to cross the blood–brain barrier. It has shown preventive effects against high blood pressure (BP) and cognitive decline in animal models and human studies. MKP shows good water solubility and...
Autores principales: | Yuda, Naoki, Tanaka, Miyuki, Tokushima, Masahiko, Abe, Fumiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866589/ https://www.ncbi.nlm.nih.gov/pubmed/33598151 http://dx.doi.org/10.1002/fsn3.2028 |
Ejemplares similares
-
Effect of the Casein-Derived Peptide Met-Lys-Pro on Cognitive Function in Community-Dwelling Adults Without Dementia: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Yuda, Naoki, et al.
Publicado: (2020) -
Neuroprotective Effects of Casein-Derived Peptide Met-Lys-Pro (MKP) in a Hypertensive Model
por: Tada, Asuka Matsuzaki, et al.
Publicado: (2020) -
Pharmaceutical Potential of Casein-Derived Tripeptide Met-Lys-Pro: Improvement in Cognitive Impairments and Suppression of Inflammation in APP/PS1 Mice
por: Matsuzaki Tada, Asuka, et al.
Publicado: (2022) -
Effects of Bifidobacterium breve B-3 on body fat reductions in pre-obese adults: a randomized, double-blind, placebo-controlled trial
por: MINAMI, Junichi, et al.
Publicado: (2018) -
Effects of Lactoferrin on Subjective Skin Conditions in Winter: A Preliminary, Randomized, Double-Blinded, Placebo-Controlled Trial
por: Oda, Hirotsugu, et al.
Publicado: (2019)